Skip to main content
Fig. 3 | Cancer Cell International

Fig. 3

From: Development of dendritic cell loaded MAGE-A2 long peptide; a potential target for tumor-specific T cell-mediated prostate cancer immunotherapy

Fig. 3

MAGE-A2 expression and cytotoxic activity against LNCaP and PC3 cell lines. A Quantitative analysis of the percentage of MAGE-A2 expression by flow cytometric assessments. B One representative dot plot of flow cytometry indicates the CFSE + PI + population. C Comparison of the percentage of cytotoxicity activity in 0:1(target only), 10:1(unstimulated and mDC stimulated CTLs) and 20:1(mDC stimulated CTLs) effector/target (E:T) ratios in LNCaP and PC3 cell lines as target cells. The data represent the mean ± SD. ns: not significant, **p ≤ 0.01, ****p ≤ 0.0001

Back to article page

Cancer Cell International

ISSN: 1475-2867

Contact us